BJDX vs TECH · rev $249.0K vs P/E 65, rev $1.22B
Bluejay Diagnostics Inc (BJDX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Bluejay Diagnostics Inc (BJDX) is a medical devices company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported BJDX revenue for 2022-12-31 was $249.0K. Net income was -$9.3M. BJDX currently screens at market cap $5.0M.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
BJDX currently screens at market cap $5.0M. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the BJDX and TECH stock pages for the full models.
Not investment advice.